Identification of LINC01503 as Biomarker Regulated by CTBP1 with Prognostic and Diagnostic Role in Epithelial Ovarian Cancer

Background: Epithelial ovarian cancer (EOC) is a disease with high morbidity and mortality worldwide, which is seriously harmful to female health. LncRNA has an important relationship with the occurrence and development of tumors. Hence, the investigation of the underlying mechanism between LncRNA and EOC is of great importance. Results: In this study, we found that LINC01503 was highly expressed in EOC with a poor prognosis based on microarray datasets GSE119056 and GSE135886 obtained from Gene Expression Omnibus (GEO) database, and this result was verified by RT-qPCR. The database lncBase Predicted v.2 and starBase v2.0 were used to predict the targeted relationship of lncRNA-miRNA-mRNA, then the ceRNA network was established by Cytoscape software. Following, the expression and overall survival (OS) analysis of key lncRNAs were analyzed by GEPIA and Kaplan-Meier plotter database. Gene Ontology (GO) functional enrichment analysis was performed by DAVID database and enriched two cancer related biological processes (BP) that response to endoplasmic reticulum stress and IRE1-mediated unfolded protein. Moreover, we verified that LINC01503 was an oncogene regulated by C-terminal binding protein 1 (CTBP1) to promote cell proliferation, migration and inhibited cell apoptosis in ovarian cancer. Conclusion: In conclusion, these results identified LINC01503 as a potential gene for EOC diagnosis and prognosis.